Format

Send to

Choose Destination
Adv Drug Deliv Rev. 2015 Mar;82-83:1-11. doi: 10.1016/j.addr.2014.10.007. Epub 2014 Oct 15.

Stem cells as drug delivery methods: application of stem cell secretome for regeneration.

Author information

1
Glickman Urological and Kidney Institute, The Cleveland Clinic, Cleveland, OH 44195 USA. Electronic address: tranc@ccf.org.
2
Cleveland Clinic Lerner College of Medicine, Lerner Research Institute, Glickman Urological and Kidney Institute, The Cleveland Clinic, Cleveland, OH 44195 USA. Electronic address: damasem@ccf.org.

Abstract

Mesenchymal stem cells (MSCs) are a unique cell population defined by their ability to indefinitely self-renew, differentiate into multiple cell lineages, and form clonal cell populations. It was originally thought that this ability for broad plasticity defined the therapeutic potential of MSCs. However, an expanding body of recent literature has brought growing awareness to the remarkable array of bioactive molecules produced by stem cells. This protein milieu or "secretome" comprises a diverse host of cytokines, chemokines, angiogenic factors, and growth factors. The autocrine/paracrine role of these molecules is being increasingly recognized as key to the regulation of many physiological processes including directing endogenous and progenitor cells to sites of injury as well as mediating apoptosis, scarring, and tissue revascularization. In fact, the immunomodulatory and paracrine role of these molecules may predominantly account for the therapeutic effects of MSCs given that many in vitro and in vivo studies have demonstrated limited stem cell engraftment at the site of injury. While the study of such a vast protein array remains challenging, technological advances in the field of proteomics have greatly facilitated our ability to analyze and characterize the stem cell secretome. Thus, stem cells can be considered as tunable pharmacological storehouses useful for combinatorial drug manufacture and delivery. As a cell-free option for regenerative medicine therapies, stem cell secretome has shown great potential in a variety of clinical applications including the restoration of function in cardiovascular, neurodegenerative, oncologic, and genitourinary pathologies.

KEYWORDS:

Mechanism of action; Mesenchymal stem cells; Regenerative medicine; Secretions; Systemic therapy; Tissue engineering

PMID:
25451858
PMCID:
PMC4398586
DOI:
10.1016/j.addr.2014.10.007
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center